212 related articles for article (PubMed ID: 30919779)
1. The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review.
Franzetti M; Ricci E; Bonfanti P
Curr HIV Res; 2019; 17(1):1-12. PubMed ID: 30919779
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients.
Rodríguez Arrondo F; von Wichmann MÁ; Camino X; Goenaga MÁ; Ibarguren M; Azcune H; Bustinduy MJ; Ferrero O; Muñoz J; Ibarra S; Aguirrebengoa K; Goicoetxea J; Bereciartua E; Montejo M; García MA; Martínez E; Portu J; Metola L; Silvariño R; Sarasqueta C; Arrizabalaga J; Iribarren JA;
Med Clin (Barc); 2018 Apr; 150(8):291-296. PubMed ID: 28528797
[TBL] [Abstract][Full Text] [Related]
3. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
4. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
Nagata N; Nishijima T; Niikura R; Yokoyama T; Matsushita Y; Watanabe K; Teruya K; Kikuchi Y; Akiyama J; Yanase M; Uemura N; Oka S; Gatanaga H
BMC Cancer; 2018 Nov; 18(1):1066. PubMed ID: 30400779
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
8. Non-AIDS-defining cancers among HIV-infected people.
Pinzone MR; Fiorica F; Di Rosa M; Malaguarnera G; Malaguarnera L; Cacopardo B; Zanghì G; Nunnari G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1377-88. PubMed ID: 23104654
[TBL] [Abstract][Full Text] [Related]
9. Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era.
Zlotorzynska M; Spaulding AC; Messina LC; Coker D; Ward K; Easley K; Baillargeon J; Mink PJ; Simard EP
BMJ Open; 2016 Apr; 6(4):e009778. PubMed ID: 27067888
[TBL] [Abstract][Full Text] [Related]
10. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.
Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P
AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240
[TBL] [Abstract][Full Text] [Related]
11. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
[TBL] [Abstract][Full Text] [Related]
12. The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.
Vaccher E; Serraino D; Carbone A; De Paoli P
Oncologist; 2014 Aug; 19(8):860-7. PubMed ID: 24969164
[TBL] [Abstract][Full Text] [Related]
13. Non--AIDS-defining malignancies in HIV.
Mitsuyasu RT
Top HIV Med; 2008; 16(4):117-21. PubMed ID: 18838745
[TBL] [Abstract][Full Text] [Related]
14. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
15. Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART.
Franzetti M; Adorni F; Parravicini C; Vergani B; Antinori S; Milazzo L; Galli M; Ridolfo AL
J Acquir Immune Defic Syndr; 2013 Apr; 62(4):414-20. PubMed ID: 23274934
[TBL] [Abstract][Full Text] [Related]
16. Malignancies in HIV: pre- and post-highly active antiretroviral therapy.
Nutankalva L; Wutoh AK; McNeil J; Frederick WR; Reddy RB; Daftary M; Gentles A; Addae-Afoakwa K
J Natl Med Assoc; 2008 Jul; 100(7):817-20. PubMed ID: 18672558
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
19. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.
Rubinstein PG; Aboulafia DM; Zloza A
AIDS; 2014 Feb; 28(4):453-65. PubMed ID: 24401642
[TBL] [Abstract][Full Text] [Related]
20. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
